Gabriel Adrian

Lund, M, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Re: Dries Develtere, Riccardo Bertolo. Cumulative Genitourinary Toxicity After Prostate Radiotherapy: High-Level Long-Term Randomized Evidence. J Clin Oncol. Online ahead of print. http://dx.doi.org/10.1200/JCO-26-00436.

Re: Dries Develtere, Riccardo Bertolo. Cumulative Genitourinary Toxicity After Prostate Radiotherapy: High-Level Long-Term Randomized Evidence. J Clin Oncol. Online ahead of print. http://dx.doi.org/10.1200/JCO-26-00436.

Journal: European urology

Published: May 29, 2026

Mitochondrial remodeling after conventional and ultra-high dose rate irradiation in head and neck carcinoma cells in vitro.

Mitochondrial remodeling after conventional and ultra-high dose rate irradiation in head and neck carcinoma cells in vitro.

Journal: Clinical and translational radiation oncology

Published: May 18, 2026

Radiotherapy with or without concurrent cetuximab in HPV-positive oropharyngeal squamous cell carcinoma - A pooled analysis from two ARTSCAN trials.

Radiotherapy with or without concurrent cetuximab in HPV-positive oropharyngeal squamous cell carcinoma - A pooled analysis from two ARTSCAN trials.

Journal: Clinical and translational radiation oncology

Published: March 31, 2026

Daily adaptive radiotherapy in head and neck squamous cell carcinoma can negatively impact organ at risk dosimetry.

Daily adaptive radiotherapy in head and neck squamous cell carcinoma can negatively impact organ at risk dosimetry.

Journal: Clinical and translational radiation oncology

Published: February 12, 2026

Six versus five fractions per week (chemo)-radiotherapy for locally advanced head and neck squamous cell carcinoma - A nationwide cohort study from the Swedish head and neck cancer register.

Six versus five fractions per week (chemo)-radiotherapy for locally advanced head and neck squamous cell carcinoma - A nationwide cohort study from the Swedish head and neck cancer register.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: December 16, 2025

External Validation of Pre-Treatment Primary Tumor Volume as a Prognostic Factor in Head and Neck Cancer Treated With (Chemo)Radiotherapy.

External Validation of Pre-Treatment Primary Tumor Volume as a Prognostic Factor in Head and Neck Cancer Treated With (Chemo)Radiotherapy.

Journal: Head & neck

Published: December 09, 2025

New modalities for ultra-high dose rate irradiation and FLASH experiments.

New modalities for ultra-high dose rate irradiation and FLASH experiments.

Journal: Physics and imaging in radiation oncology

Published: November 24, 2025

Circulating Tumor DNA in Human Papilloma Virus-Positive Oropharyngeal Squamous Cell Carcinoma-Are We Ready to Individualize Treatment?

Circulating Tumor DNA in Human Papilloma Virus-Positive Oropharyngeal Squamous Cell Carcinoma-Are We Ready to Individualize Treatment?

Journal: International journal of radiation oncology, biology, physics

Published: October 06, 2025

Routinely collected health data on 10-year genitourinary and gastrointestinal morbidity after ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer in the randomised, non-inferiority, phase 3 trial HYPO-RT-PC.

Routinely collected health data on 10-year genitourinary and gastrointestinal morbidity after ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer in the randomised, non-inferiority, phase 3 trial HYPO-RT-PC.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: August 28, 2025

Photon FLASH spares radiation-induced changes in cardiac function, remodelling and arrythmia in a preclinical model.

Photon FLASH spares radiation-induced changes in cardiac function, remodelling and arrythmia in a preclinical model.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: July 31, 2025

Not all tumors are alike: varying efficacy of FLASH across tumor types and oxygenation status in spheroid models.

Not all tumors are alike: varying efficacy of FLASH across tumor types and oxygenation status in spheroid models.

Journal: The British journal of radiology

Published: May 22, 2025

Chemoradiation Therapy Versus Radiation Therapy Alone in T1-2 Oropharyngeal Cancer With Low-Volume Neck Disease: A Population-Based Cohort Study Using the Swedish Head and Neck Cancer Register.

Chemoradiation Therapy Versus Radiation Therapy Alone in T1-2 Oropharyngeal Cancer With Low-Volume Neck Disease: A Population-Based Cohort Study Using the Swedish Head and Neck Cancer Register.

Journal: International journal of radiation oncology, biology, physics

Published: April 30, 2025

Showing 1-12 of 33

Last Updated: 09/26/2026